• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

George A. Scangos - Articles and news items

Biogen Idec logo

Health Canada approves Biogen Idec’s long-acting alprolix™ therapy for hemophilia B

Industry news / 21 March 2014 / Biogen Idec

The approval of ALPROLIX is first significant advance in hemophilia B treatment in more than 17 years …

Biogen Idec logo

Eisai and Biogen Idec enter collaboration to develop and commercialize alzheimer’s disease treatments

Industry news / 5 March 2014 / Biogen Idec

Agreement to enhance R&D capabilities and pipeline aimed at creating new therapies to suppress Alzheimer’s disease progression…

Biogen Idec logo

William D. Young to retire from Biogen Idec’s Board of Directors

Industry news / 17 February 2014 / Biogen Idec

Stelios Papadopoulos to become Chairman of the Board…

Biogen Idec logo

Tecfidera® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis

Industry news / 3 February 2014 / Biogen Idec

Biogen Idec to begin launching TECFIDERA in initial EU Countries in the coming weeks…

Biogen Idec logo

Biogen Idec completes purchase of full rights and control of TYSABRI®

Industry news, News / 2 April 2013 / Biogen Idec

Biogen Idec has completed its purchase of Elan Corporation’s interest in TYSABRI® (natalizumab)…

Biogen Idec logo
Biogen Idec logo

CHMP issues positive opinion for TECFIDERA(TM) as a first-line treatment for MS in the European Union

Industry news, News / 22 March 2013 / GCI Health

European Commission decision anticipated in second quarter of 2013…

Biogen Idec logo

Biogen Idec to acquire full rights and control of TYSABRI® from Elan for upfront cash and contingent payments

Industry news, News / 6 February 2013 / Biogen Idec

Biogen Idec has agreed to purchase Elan’s interest in TYSABRI…

Biogen Idec logo

Biogen Idec opens new RTP facility

Industry news, News / 29 November 2012 / Biogen Idec

Biogen Idec dedicated a new facility in Research Triangle Park (RTP), consolidating its 300-person Patient Services operation with the existing RTP campus…

Biogen Idec logo

Biogen Idec appoints Kenneth DiPietro Executive Vice President Human Resources

Industry news, News / 30 January 2012 / Biogen Idec

Kenneth DiPietro named Executive Vice President, Human Resources…

Biogen Idec logo

Biogen Idec and Isis Pharmaceuticals announce global collaboration

Industry news, News / 4 January 2012 / Biogen Idec

Biogen Idec and Isis Pharmaceuticals, Inc. have entered into an exclusive, worldwide option and collaboration agreement…

Biogen Idec logo

Samsung and Biogen Idec announce joint venture to develop, manufacture and market biosimilars

Industry news, News / 5 December 2011 / Biogen Idec

Samsung and Biogen Idec announced that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +